Oregon Health & Science University — Quarterly 13F Portfolio Report
Oregon Health & Science University
CIK: 0001833471
Long-term holder
Total reported value
—
Reporting period: 2022-12-31 · Number of holdings: 1
Oregon Health & Science University disclosed 1 holdings in its latest 13F filing for the period ending 2022-12-31, with total reported value of — and a quarterly turnover rate of 0.0%.
Sector classification currently covers about 0% of this portfolio's disclosed value; the remainder includes holdings (e.g. unmapped tickers, options, or other security types) not yet covered by our sector mapping.
Position changes disclosed by Oregon Health & Science University for the quarter ending 2022-12-31, including ticker, issuer, weight change, shares change, and action
What is Oregon Health & Science University and what type of investor is it?
Oregon Health & Science University is a investment manager that files SEC Form 13F quarterly, disclosing its U.S. public equity holdings to regulators. As of the most recent reporting period (2022-12-31), the firm manages a tracked equity portfolio valued at approximately —, spread across 1 disclosed positions.
What are Oregon Health & Science University's largest equity positions?
Based on the latest 13F filing, Oregon Health & Science University's top holdings by market value are:
1. Alliqua, Inc. — $0.0
What changes did Oregon Health & Science University make in its most recent portfolio filing?
No notable portfolio changes were recorded for Oregon Health & Science University in the most recent quarter. Holdings appear to have remained relatively stable.
What sectors does Oregon Health & Science University focus on?
Sector breakdown data is not yet available for Oregon Health & Science University. Check back after the next 13F processing cycle.